MYO Strangle Strategy
MYO (Myomo, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on AMEX.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
MYO (Myomo, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $31.4M, a beta of 1.39 versus the broader market, a 52-week range of 0.605-3.685, average daily share volume of 361K, a public-listing history dating back to 2017, approximately 184 full-time employees. These structural characteristics shape how MYO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.39 indicates MYO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on MYO?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current MYO snapshot
As of May 15, 2026, spot at $0.92, ATM IV 23.40%, IV rank 1.24%, expected move 6.71%. The strangle on MYO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on MYO specifically: MYO IV at 23.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a MYO strangle, with a market-implied 1-standard-deviation move of approximately 6.71% (roughly $0.06 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MYO expiries trade a higher absolute premium for lower per-day decay. Position sizing on MYO should anchor to the underlying notional of $0.92 per share and to the trader's directional view on MYO stock.
MYO strangle setup
The MYO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MYO near $0.92, the first option leg uses a $0.97 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MYO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MYO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.97 | N/A |
| Buy 1 | Put | $0.87 | N/A |
MYO strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MYO strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MYO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on MYO
Strangles on MYO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MYO chain.
MYO thesis for this strangle
The market-implied 1-standard-deviation range for MYO extends from approximately $0.86 on the downside to $0.98 on the upside. A MYO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MYO IV rank near 1.24% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MYO at 23.40%. As a Healthcare name, MYO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MYO-specific events.
MYO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MYO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MYO alongside the broader basket even when MYO-specific fundamentals are unchanged. Always rebuild the position from current MYO chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MYO?
- A strangle on MYO is the strangle strategy applied to MYO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MYO stock trading near $0.92, the strikes shown on this page are snapped to the nearest listed MYO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MYO strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MYO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 23.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MYO strangle?
- The breakeven for the MYO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MYO market-implied 1-standard-deviation expected move is approximately 6.71%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MYO?
- Strangles on MYO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MYO chain.
- How does current MYO implied volatility affect this strangle?
- MYO ATM IV is at 23.40% with IV rank near 1.24%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.